Amber Graham
Physical Medicine & Rehabilitation · Memphis, TNNPI 1679849483
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $338 of the $376 with a category attached, or 89.9%. AbbVie accounts for 78.1% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $181, 3.6 times the $50 reported in 2019.
Across 18 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$294
- Acorda Therapeutics, Inc$38
- Johnson & Johnson$32
- Pfizer$12
What the payments were for
- Speaking & faculty fees$3810%
- Food & beverage$33890%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $294 |
| Acorda Therapeutics, Inc | 2 | $38 |
| Johnson & Johnson | 1 | $32 |
| Pfizer | 1 | $12 |
How this compares
$376 in reported general payments places this provider in the 55th percentile of 134 physical medicine & rehabilitation providers in Tennessee.
See all physical medicine & rehabilitation providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 225 | $2,455 |
| Pregabalin | 50 | $986 |
| Cyclobenzaprine Hcl | 25 | $249 |
| Tizanidine Hcl | 16 | $172 |
| Methocarbamol | 18 | $113 |
| Methylprednisolone | 15 | $82 |
| Alprazolam | 15 | $7 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Memphis
- Danielle HasselMemphis$507
- Chris CovingtonMemphis$319
- David BowersChattanooga$41K
- Son leMt. Juliet$28K
- Terence DunnChattanooga$14K
- Sandra GolamcoNashville$13K
- Wesley PeaceNashville$9K
- Michael McGuirkOak Ridge$9K
- Santos MartinezGermantown$7K
- Brandon TolmanBrentwood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.